Corcept Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CORT and other ETFs, options, and stocks.

About CORT

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol.

CEO

Joseph K. Belanoff

CEOJoseph K. Belanoff

Employees

352

Employees352

Headquarters

Menlo Park, California

HeadquartersMenlo Park, California

Founded

1998

Founded1998

Employees

352

Employees352

CORT Key Statistics

Market cap

2.87B

Market cap2.87B

Price-Earnings ratio

25.95

Price-Earnings ratio25.95

Dividend yield

—

Dividend yield—

Average volume

1.18M

Average volume1.18M

High today

$27.93

High today$27.93

Low today

$27.36

Low today$27.36

Open price

$27.67

Open price$27.67

Volume

718.50K

Volume718.50K

52 Week high

$34.28

52 Week high$34.28

52 Week low

$20.84

52 Week low$20.84

CORT News

Yahoo Finance 4d

Pipeline Moves: Phase III completion for Corcept's relaorilant - Yahoo Finance

This week on Pipeline Moves, we kick off by looking at the completion of a Phase III trial by Corcept Therapeutics of its candidate relacorilant in Cushing’s sy...

Simply Wall St 5d

Is Corcept Therapeutics Incorporated's Latest Stock Performance A Reflection Of Its Financial Health? - Simply Wall St

Corcept Therapeutics (NASDAQ:CORT) has had a great run on the share market with its stock up by a significant 15% over the last month. Given the company's impre...